Clean Vision Corp (CLNV) income statement
CLNVOTCIndustrial Organic ChemicalsFiscal year ends December 31
$0.00+0.00 (+16.67%)
Close on Oct 19, 2026Market cap $3.69MP/E –Yield –
Clean Vision Corp financial ratios
See a number that looks wrong?
Close on Oct 19, 2026Market cap $3.69MP/E –Yield –
See a number that looks wrong?
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin | 95.1% | 63.2% | – | – |
| Operating margin | -3,163.5% | -3,368.2% | – | – |
| EBITDA margin | -3,067.5% | -3,359.5% | – | – |
| Pre-tax margin | -6,138.4% | -5,593.1% | – | – |
| Net profit margin | -6,060.9% | -5,543.4% | – | – |
| Returns on capital | ||||
| Return on equity | 175.6% | 378.6% | 344.6% | – |
| Return on assets | -118.4% | -260.2% | -1,563.6% | – |
| Return on tangible assets | -200.8% | -2,267.5% | -1,563.6% | – |
| Return on capital employed | 241.0% | 766.0% | – | – |
| NOPAT | -$5.77M | -$6.85M | – | – |
| Cash flow quality | ||||
| OCF / Sales | -2,106.9% | -1,825.7% | – | – |
| OCF / Net income | 0.35 | 0.33 | 0.34 | – |
| Efficiency | ||||
| Asset turnover | 0.02 | 0.05 | – | – |
| Fixed asset turnover | 0.05 | 0.10 | – | – |
| Receivables turnover | 4.26 | 3.64 | – | – |
| Days sales outstanding | 85.6 | 100.3 | – | – |
| Payables turnover | 0.01 | 0.17 | – | – |
| Days payables outstanding | 28,752.5 | 2,190.5 | – | – |
| Liquidity | ||||
| Current ratio | 0.19 | 0.08 | 0.07 | – |
| Quick ratio | 0.19 | 0.08 | 0.07 | – |
| Cash ratio | 0.05 | 0.03 | 0.01 | – |
| Working capital | -$15.03M | -$10.42M | -$1.82M | – |
| Net current asset value | -$21.55M | -$12.17M | -$1.82M | – |
| Leverage | ||||
| Assets to equity | -1.10 | -2.50 | -0.11 | – |
| Goodwill / Assets | 37.2% | 45.8% | – | – |
| Intangibles to total assets | 37.2% | 45.8% | – | – |
| Interest coverage | ||||
| EBIT / Interest expense | -1.32 | -1.81 | – | – |
| EBITDA / Interest expense | -1.28 | -1.80 | – | – |
| Per share | ||||
| Revenue per share | 0.0003 | 0.0004 | – | – |
| EPS (basic) | -0.02 | -0.03 | – | – |
| EPS (diluted) | -0.02 | -0.03 | – | – |
| Book value per share | -0.01 | -0.0062 | -0.0084 | – |
| Tangible book value per share | -0.02 | -0.01 | -0.0084 | – |
| Cash per share | 0.0011 | 0.0005 | 0.0000 | – |
| Operating cash flow per share | -0.0060 | -0.0069 | -0.0050 | – |
| Valuation at period end | ||||
| Market cap | $14.41M | $24.99M | – | – |
| Enterprise value | $14.41M | $23.69M | – | – |
| P/S | 62.4x | 97.1x | – | – |
| P/B | -1.2x | -5.9x | – | – |
| P/TBV | -0.9x | -2.7x | – | – |
| P/Gross profit | 65.6x | 154x | – | – |
| P/OCF | -3.0x | -5.3x | – | – |
| EV/Sales | 62.4x | 92.0x | – | – |
| EV/Gross profit | 65.6x | 146x | – | – |
| EV/OCF | -3.0x | -5.0x | – | – |
| Earnings yield | -97.2% | -57.1% | – | – |
| Cost structure | ||||
| R&D to revenue | 144.8% | 95.1% | – | – |
| SG&A to revenue | – | 414.2% | – | – |
| Stock-based comp to revenue | 309.0% | 367.3% | – | – |
| Per employee | ||||
| Total employees | 38 | 38 | 90 | 90 |
| Revenue per employee | $6.08K | $6.77K | – | – |
| Gross profit per employee | $5.78K | $4.28K | – | – |
| Operating profit per employee | -$192.34K | -$228.17K | – | – |
| Net income per employee | -$368.51K | -$375.51K | -$65.52K | – |
| Growth | ||||
| Revenue 1Y growth | -10.2% | – | – | – |
| Gross profit 1Y growth | 34.9% | – | – | – |
| EBIT 1Y growth | 15.7% | – | – | – |
| EBITDA 1Y growth | 18.0% | – | – | – |
| Net income 1Y growth | 1.9% | -142.0% | – | – |
| Diluted EPS 1Y growth | 33.3% | – | – | – |
| Operating cash flow 1Y growth | -3.6% | -131.6% | – | – |
| Total assets 1Y growth | 23.4% | 2,708.1% | – | – |
| Total equity 1Y growth | -180.9% | -25.4% | -7,442.6% | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.